Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)
Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –
Eton Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eton Pharmaceuticals's price to book ratio was 41.5× on Nov 11, 2026, against 18.7× a year earlier. Over the last 5 years it ranged from 4.0× to 41.5×, with a median of 7.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 41.5× | +21.9 |
| 2025 | Dec 31, 2025 | 19.6× | −1.9 |
| 2024 | Dec 31, 2024 | 21.5× | +14.9 |
| 2023 | Dec 29, 2023 | 6.7× | +0.3 |
| 2022 | Dec 30, 2022 | 6.4× | −0.4 |
| 2021 | Dec 31, 2021 | 6.7× | −116.2 |
| 2020 | Dec 31, 2020 | 122.9× | +112.6 |
| 2019 | Dec 31, 2019 | 10.4× | – |
See a number that looks wrong?